Exploring optimal sequence of abiraterone and enzalutamide in patients with castration-resistant prostate cancer: The Kyoto-Baltimore collaboration.

Authors

null

Naoki Terada

Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan

Naoki Terada , Benjamin Louis Maughan , Shusuke Akamatsu , Takashi Kobayashi , Toshinari Yamasaki , Takahiro Inoue , Tomomi Kamba , Osamu Ogawa , Emmanuel S. Antonarakis

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 35, 2017 (suppl 6S; abstract 219)

DOI

10.1200/JCO.2017.35.6_suppl.219

Abstract #

219

Poster Bd #

H21

Abstract Disclosures

Similar Posters

First Author: Akiyuki Yamamoto

First Author: Constance Thibault

Poster

2017 Genitourinary Cancers Symposium

Early docetaxel-resistance in metastatic hormone-sensitive prostate cancer.

Early docetaxel-resistance in metastatic hormone-sensitive prostate cancer.

First Author: Nedal Bukhari